FDA
approval
· 2024-10-29
FDA Approved: DEFLAZACORT ORAL SUSPENSION — Supplemental Application (Cranbury Pharmaceuticals, LLC)
Summary
The FDA approved a supplemental application for Deflazacort oral suspension by Cranbury Pharmaceuticals, expanding the availability of deflazacort in oral suspe…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DEFLAZACORT ORAL SUSPENSION (DEFLAZACORT ORAL)